Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Medline Inc. (MDLN)

Medline Q3 net sales rise 10.4% to $7.9 billion; net income dips 1.2%, organic sales guidance raised

Mixed Impact 4 of 5 earnings Written later

Medline reported third quarter 2026 net sales of $7.9 billion, up 10.4%, while net income fell 1.2% to $318 million, with the company citing higher inventory costs, operating expenses and customer mix, partly offset by $81 million of net IEEPA tariff refund benefits. The company raised its full-year 2026 Organic Sales growth outlook to 10.0% to 10.5%, reaffirmed Adjusted EBITDA guidance of $3.3 billion to $3.4 billion, and its board authorized a $1 billion share repurchase program.

Key points

  • Q3 2026 net income was $318 million, down from $322 million; diluted EPS was $0.22
  • Q3 2026 Adjusted EBITDA rose 11.8% to $960 million from $859 million
  • Full-year 2026 Organic Sales growth guidance raised to 10.0% to 10.5% from 9.0% to 10.0%; Adjusted EBITDA guidance reaffirmed at $3.3 billion to $3.4 billion
  • Board approved a $1 billion share repurchase program in October 2026, and $750 million of the 2033 Refinancing Term Loan Facility was prepaid

The filing

CompanyMedline Inc. (MDLN)
Form8-K, current report
Filed with the SECNov 4, 2026, 7:34 AM ET
Accession number0002046386-26-000060

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.